It is the FDA's current, evolving determination of which peptide bulk substances may be used by compounding pharmacies under Section 503A of the FD&C Act, organized through interim Category 1 (generally compoundable while under evaluation) and Category 2 (flagged for significant safety risk and effectively off-limits) classifications
Those focused on energy enhancement might prioritize mitochondrial peptides like MOTS-c
In one study, TB-500 sulfoxide, produced by monocytes upon glucocorticoid administration, was found to inhibit neutrophil chemotaxis and exhibit potent anti-inflammatory effects [9]
Bacteriostatic Water is a sterile water solution preserved with 0.9% benzyl alcohol, which inhibits the growth of bacteria and allows for multiple withdrawals from a single vial without compromising sterility
Glutathione conjugates to NAPQI, and the resulting ensemble is excreted
Imbalanced homocysteine isn't just a risk to cardiovascular risk factor, it can also impair the transsulfuration pathway [7]
